Comment on Shao et al.'s "Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic"

Hsiu-Ming Lee¹, Po-Cheng Shih^{2

3}, James Cheng-Chung Wei^{2

4

5}

Affiliations

¹ School of Medicine, China Medical University, Taichung, Taiwan.
² Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
³ Department of Allergy, Immunology and Rheumatology, Changhua Christian Hospital, Changhua, Taiwan.
⁴ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁵ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

Comment

Hsiu-Ming Lee et al. J Med Virol. 2024 Jan.

. 2024 Jan;96(1):e29383.

doi: 10.1002/jmv.29383.

Hsiu-Ming Lee¹, Po-Cheng Shih^{2

3}, James Cheng-Chung Wei^{2

4

5}

¹ School of Medicine, China Medical University, Taichung, Taiwan.
² Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
³ Department of Allergy, Immunology and Rheumatology, Changhua Christian Hospital, Changhua, Taiwan.
⁴ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁵ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

No abstract available

Comment on

Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
Shao C, Shi Y, Chen R, Liu X, Huang H, Zhao Y, Xu K, Chen K, Wang M, Xu Z. Shao C, et al. J Med Virol. 2023 Sep;95(9):e29098. doi: 10.1002/jmv.29098. J Med Virol. 2023. PMID: 37707416